¼¼°èÀÇ Ã¼¿Ü Æó ¸ðµ¨ ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Global In Vitro Lung Model Market, By Type, By Application, By End User, By Geography
»óǰÄÚµå : 1708317
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,236,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,700,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,858,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü ¼¼°è ü¿Ü Æó ¸ðµ¨ ½ÃÀåÀº 2025³â¿¡ 3¾ï 3,800¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2032³â±îÁö 8¾ï 6,660¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 14.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 3¾ï 3,800¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR: 14.40% 2032³â °¡Ä¡ ¿¹Ãø 8¾ï 6,660¸¸ ´Þ·¯
±×¸². ü¿Ü Æó ¸ðµ¨ ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Global In Vitro Lung Model Market-IMG1

ü¿Ü Æó ¸ðµ¨Àº Àΰ£ ÆóÀÇ »ý¸®Àû, ÇØºÎÇÐÀû Ư¼ºÀ» ¸ð¹æÇϱâ À§ÇÑ ½ÇÇè ½Ã½ºÅÛÀÔ´Ï´Ù. ½Å¾à°³¹ß, µ¶¼º ½ÃÇè, ÆóÁúȯ ¿¬±¸¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ü¿Ü¿¡¼­ ¹è¾çÇÑ Àΰ£ Æó ¼¼Æ÷ ¹× Á¶Á÷À» ÀÌ¿ëÇÔÀ¸·Î½á, ÀÌµé ¸ðµ¨Àº µ¿¹° ½ÇÇè¿¡ ºñÇØ »ó´ëÀûÀ¸·Î Àú·ÅÇϰí È¿°úÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ µ¿¹° ¸ðµ¨°ú ºñ±³ÇÏ¿© º¸´Ù Çö½ÇÀûÀ̰í Á¦¾î °¡´ÉÇÑ È¯°æÀ» Á¦°øÇÏ¿© Àΰ£ ÆóÀÇ »ý¹°ÇÐ ¹× Áúº´ º´Å¸¦ ¿¬±¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇâÈÄ Á¶Á÷°øÇÐ, ¹Ì¼¼À¯Ã¼°øÇÐ ¹× ±âŸ ±â¼úÀÇ ¹ßÀüÀ¸·Î »ýü ³» Æó ¹Ì¼¼ ȯ°æÀ» ´õ Àß ÀçÇöÇÒ ¼ö ÀÖ´Â °íµµ·Î º¹ÀâÇÑ 3D Æó ¸ðµ¨ °³¹ß¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ü¿Ü Æó ¸ðµ¨ ½ÃÀåÀº Á¦¾àȸ»çÀÇ ÀǾàǰ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡, µ¿¹°½ÇÇè¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦, È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü 3D Æó ¸ðµ¨ °³¹ß¿¡ µû¸¥ ³ôÀº ºñ¿ë°ú ªÀº Á¶Á÷ º¸Á¸ ±â°£ÀÌ ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¹Ì¼¼ °¡°ø ±â¼ú ¹× 3D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ±â¼úÀÇ ¹ßÀüÀ¸·Î Â÷¼¼´ë »ýü ¸ð¹æ ¸ðµ¨ °³¹ß¿¡ Å« ±âȸ°¡ âÃâµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, °³º° ȯÀÚ À¯·¡ÀÇ ¼¼Æ÷ ¹× Á¶Á÷ÀÌ Æ÷ÇÔµÈ ¸ÂÃãÇü Æó ¸ðµ¨ °³¹ßÀÌ ÁÖ¸ñ¹Þ°í ÀÖ¾î ½ÃÀå È®´ë°¡ ¿¹»óµË´Ï´Ù.

ÇÑÆí, ½ÃÀå ÁøÀÔ ±â¾÷µéÀÇ ¿¬±¸°³¹ßÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù 6ÀÏ »ý¸í°øÇÐ ±â¾÷ AlveoliX AG´Â Frontiers Media S.A.¿¡ õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ¼¶À¯Áõ°ú °°Àº ´Ù¾çÇÑ È£Èí±âÁúȯ¿¡ ´ëÇØ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ °³¹ßÇÑ ¾à¹°ÀÇ ¼ö°¡ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip"À̶ó´Â Á¦¸ñÀÇ ¿¬±¸¸¦ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌ·¯ÇÑ ½É°¢ÇÑ Æó Áúȯ¿¡ ´ëÇØ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ ½ÂÀÎÇÑ ÈíÀÔ ¾à¹°ÀÇ ¼ö°¡ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ÀüÀÓ»ó ¿¬±¸¿¡¼­ ÈíÀÔ ÀÔÀÚÀÇ µ¶¼ºÀ» º¸´Ù Á¤È®ÇÏ°Ô ¿¹ÃøÇϱâ À§ÇØ »ýü ³»¿¡¼­ ´ëüÇÒ ¼ö ÀÖ´Â »ýü ¿Ü ÀÎü °ü·Ã ¸ðµ¨ »ç¿ëÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ Ã¼¿Ü Æó ¸ðµ¨ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Ã¼¿Ü Æó ¸ðµ¨ ½ÃÀå, À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ Ã¼¿Ü Æó ¸ðµ¨ ½ÃÀå, ¿ëµµº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ Ã¼¿Ü Æó ¸ðµ¨ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ Ã¼¿Ü Æó ¸ðµ¨ ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global In Vitro Lung Model Market is estimated to be valued at USD 338.0 Mn in 2025 and is expected to reach USD 866.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 14.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 338.0 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.40% 2032 Value Projection: USD 866.6 Mn
Figure. Global In Vitro Lung Model Market Share (%), By Region 2025
Global In Vitro Lung Model Market - IMG1

In vitro lung models are experimental systems that aim to mimic the physiological and anatomical properties of the human lungs. They are widely used in drug discovery, toxicity testing, and studying lung diseases. By utilizing human lung cells and tissues grown outside of the body, these models offer a relatively affordable and effective alternative to animal testing. They also provide a more realistic and controllable environment to study human lung biology and disease pathology compared to animal models. Going forward, advances in tissue engineering, microfluidics, and other technologies are expected to help develop highly complex 3D lung models that can better recreate the in vivo lung microenvironment.

Market Dynamics:

The global in vitro lung model market is driven by factors such as rising drug R&D investments by pharmaceutical companies, stringent regulations regarding animal testing, and increasing prevalence of respiratory diseases. However, high costs associated with developing advanced 3D lung models and shorter shelf life of tissues are expected to restrain the market growth. Meanwhile, ongoing advances in microfabrication and 3D bioprinting technologies are projected to create significant opportunities for manufacturers to develop next-gen biomimetic models. The market is also anticipated to gain from growing focus on developing personalized lung models incorporating individual patient-derived cells and tissues.

On the other hand, rising research and development by market players is further expected to propel the market growth over the forecast period. For instance, on March 6, 2024, AlveoliX AG, a biotechnology company, published a study in Frontiers Media S.A., a peer-reviewed, open access, scientific journals, entitled "A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip" for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and fibrosis, due to limited number of U.S. Food and Drug Administration, approved inhaled drugs for these serious lung conditions has led to a shift from in vivo towards the use of alternative in vitro human-relevant models to better predict the toxicity of inhaled particles in preclinical research.

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global In Vitro Lung Model Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global In Vitro Lung Model Market, By Type, 2020-2032, (US$ Mn)

6. Global In Vitro Lung Model Market, By Application, 2020-2032, (US$ Mn)

7. Global In Vitro Lung Model Market, By End User, 2020-2032, (US$ Mn)

8. Global In Vitro Lung Model Market, By Region, 2020-2032, (US$ Mn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â